NIH expands trials of convalescent plasma against Covid-19
The US National Institutes of Health (NIH) has increased the enrolment target in two clinical trials testing convalescent plasma as…
Latest News
-
12 hours
-
17 hours
-
21 hours
-
2 days
-
2 days
-
2 days
-
2 days
-
3 days
Vaccinex’s pepinemab fails in Phase II Huntington’s disease trial
Vaccinex has said that the Phase II SIGNAL trial of its pepinemab failed to meet pre-specified co-primary endpoints in patients…
Latest News
View More
Petrovax begins dosing in Phase III trial of CanSino’s Covid-19 vaccine
Russia's Petrovax Pharm has started dosing participants in a Phase III clinical trial of Ad5-nCoV Covid-19 vaccine candidate developed by China-based CanSino Biologics and Beijing…
BMS reports positive data of Opdivo in renal cell carcinoma trial
Bristol Myers Squibb (BMS) and Exelixis have reported that an Opdivo (nivolumab) and Cabometyx (cabozantinib) combination showed significant improvements across all efficacy endpoints in the…
Seattle Genetics-Astellas’ Padcev meets primary goal in urothelial cancer
Seattle Genetics and Astellas Pharma have reported that Padcev (enfortumab vedotin-ejfv) achieved its primary endpoint of overall survival in a…
Lynparza lowers death risk in Phase III prostate cancer trial
AstraZeneca and MSD (Merck) have reported that Lynparza (olaparib) reduced the risk of death by 31% in men with metastatic…
Rigel launches Phase II trial to assess fostamatinib for Covid-19
Rigel Pharmaceuticals has launched a Phase II clinical trial to test the safety of fostamatinib to treat hospitalised Covid-19 patients.…
Roche’s Actemra reduces need for mechanised ventilation in Covid-19 patients
Roche has reported that its Actemra/RoActemra (tocilizumab) reduced the need for mechanical ventilation in hospitalised Covid-19 patients with associated pneumonia…
Latest Content
View More
Atossa Therapeutics reports positive safety data of Covid-19 drug
Atossa Therapeutics has reported positive interim safety data from the second cohort of participants in a Phase I clinical trial…
Feinstein Institutes reports positive data of lupus nephritis drug
The Feinstein Institutes for Medical Research and Northwell Health’s Division of Rheumatology in the US have announced improved renal response…
Gavreto (pralsetinib) for the Treatment of Non-Small Cell Lung Cancer (NSCLC)
Gavreto™ (pralsetinib) is a targeted therapy indicated for the treatment of metastatic rearranged during transfection (RET) fusion-positive non-small cell lung…
Why Switch to Automated CRF Annotations?
Annotated CRFs document the location in a database of the data collected for each question on a form. It is…
A Guide to CDISC Standards Used in the Clinical Research Process
The Clinical Data Interchange Standards Consortium is an organisation dedicated to helping to improve medical research by driving communication through…